LUV
43
4
AEP
51
6
CRM
59
2
A
40
-4
HRB
55
3
MCO
73
2
FLR
66
11
ICE
55
2
WDC
55
2
CA
14
10
EMC
68
6
NVDA
60
3
PDCO
46
3
NWSA
54
2
SO
68
2
ACN
70
14
GS
76
4
TXN
42
2
VIX
38
-8
LRCX
39
-3
LUV
43
4
AEP
51
6
CRM
59
2
A
40
-4
HRB
55
3
MCO
73
2
FLR
66
11
ICE
55
2
WDC
55
2
CA
14
10
EMC
68
6
NVDA
60
3
PDCO
46
3
NWSA
54
2
SO
68
2
ACN
70
14
GS
76
4
TXN
42
2
VIX
38
-8
LRCX
39
-3
Financhill
Back

Direxion Daily S&P 500® Hi Bt Bl 3X ETF Vs. Kymera Therapeutics Industry Stock Comparison

Buy
79

HIBL
Direxion Daily S&P 500® Hi Bt Bl 3X ETF

Last Price:
46.85
Seasonality Move:
52.38%
Buy
71

KYMR
Kymera Therapeutics

Last Price:
48.99
Seasonality Move:
65.72%
Buy
79
Direxion Daily S&P 500® Hi Bt Bl 3X ETF (HIBL) is a Buy

Is Direxion Daily S&P 500® Hi Bt Bl 3X ETF a Buy, Sell or Hold?

  • The current Direxion Daily S&P 500® Hi Bt Bl 3X ETF [HIBL] share price is $46.82. The Score for HIBL is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
  • HIBL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
71
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $49.02. The Score for KYMR is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

HIBL Stock Price Chart

What is Direxion Daily S&P 500® Hi Bt Bl 3X ETF's stock price today?

  • The Direxion Daily S&P 500® Hi Bt Bl 3X ETF share price today is $46.82
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HIBL is experiencing slight buying pressure.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $49.02
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.

HIBL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.76 Buy
Relative Strength Index (14 RSI): 59.07 Buy
Chaikin Money Flow: 7404 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.37 - 46.57) Buy
Bollinger Bands (100): (37.49 - 45.17) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 59.12 Buy
Chaikin Money Flow: 317205 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.81 - 49.49) Buy
Bollinger Bands (100): (34.86 - 47.92) Buy

HIBL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 46.4 Buy
20-day SMA: 45.04 Buy
50-day SMA: 40.78 Buy
200-day SMA: 41.61 Buy
8-day EMA: 46.33 Buy
20-day EMA: 44.69 Buy
50-day EMA: 42.54 Buy
200-day EMA: 40.36 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.58 Buy
20-day SMA: 46.67 Buy
50-day SMA: 46.11 Buy
200-day SMA: 38.62 Buy
8-day EMA: 45.67 Buy
20-day EMA: 45.85 Buy
50-day EMA: 45.2 Buy
200-day EMA: 38.5 Buy

Direxion Daily S&P 500® Hi Bt Bl 3X ETF Earnings Growth & HIBL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.

Direxion Daily S&P 500® Hi Bt Bl 3X ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):